Ascendis Pharma A/S
ASND225.537USD
+1.587+0.71%
取引時間 （ET）15分遅れの株価
13.91B時価総額
損失額直近12ヶ月PER
詳細情報 Ascendis Pharma A/S 企業名
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ascendis Pharma A/Sの企業情報
企業コードASND
会社名Ascendis Pharma A/S
上場日Jan 28, 2015
最高経営責任者「CEO」Moller Mikkelsen (Jan)
従業員数- -
証券種類Depository Receipt
決算期末Jan 28
本社所在地Tuborg Boulevard 12
都市HELLERUP
証券取引所NASDAQ OMX - NASDAQ BASIC
国Denmark
郵便番号2900
電話番号4570222244
ウェブサイトhttps://ascendispharma.dk/
企業コードASND
上場日Jan 28, 2015
最高経営責任者「CEO」Moller Mikkelsen (Jan)
Ascendis Pharma A/Sの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+3832.00%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+701.00%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+696.00%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+696.00%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
+364.00%
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
+193.00%
Mr. Jan Moller Mikkelsen
Mr. Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
President, Chief Executive Officer, Executive Director, Member of the Executive Board
--
--
Ms. Lotte Soenderbjerg
Ms. Lotte Soenderbjerg
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
--
--
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
--
--
Dr. Kennett Sprogoee, Ph.D.
Dr. Kennett Sprogoee, Ph.D.
Executive Vice President, Head of Innovation and Research
Executive Vice President, Head of Innovation and Research
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+3832.00%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+701.00%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+696.00%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+696.00%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
+364.00%
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
+193.00%
収益内訳
通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Commercial sale of products
193.79M
90.71%
Milestones
12.92M
6.05%
Rendering of services
6.13M
2.87%
License
788.00K
0.37%
地域別USD
会社名
収益
比率
North America
161.13M
75.42%
Europe
29.28M
13.71%
Rest of world
19.12M
8.95%
Denmark
4.10M
1.92%
事業別
地域別
事業別USD
会社名
収益
比率
Commercial sale of products
193.79M
90.71%
Milestones
12.92M
6.05%
Rendering of services
6.13M
2.87%
License
788.00K
0.37%
株主
更新時刻: Thu, Dec 4
更新時刻: Thu, Dec 4
株主統計
種類
株主統計
株主統計
比率
RA Capital Management, LP
16.59%
Westfield Capital Management Company, L.P.
8.49%
Avoro Capital Advisors LLC
8.24%
Janus Henderson Investors
6.98%
Fidelity Management & Research Company LLC
6.65%
他の
53.06%
株主統計
株主統計
比率
RA Capital Management, LP
16.59%
Westfield Capital Management Company, L.P.
8.49%
Avoro Capital Advisors LLC
8.24%
Janus Henderson Investors
6.98%
Fidelity Management & Research Company LLC
6.65%
他の
53.06%
種類
株主統計
比率
Investment Advisor/Hedge Fund
43.30%
Investment Advisor
36.23%
Venture Capital
16.84%
Hedge Fund
4.59%
Research Firm
2.38%
Private Equity
2.28%
Individual Investor
0.76%
Pension Fund
0.36%
Bank and Trust
0.01%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
523
68.62M
116.45%
+3.30K
2025Q3
540
68.73M
112.39%
+4.25M
2025Q2
515
64.43M
118.51%
-2.60M
2025Q1
495
67.05M
117.13%
-3.67M
2024Q4
471
65.26M
121.58%
+1.14M
2024Q3
461
64.02M
116.74%
+1.57M
2024Q2
446
62.31M
123.50%
-4.72K
2024Q1
440
62.32M
122.74%
-9.15M
2023Q4
415
61.74M
123.84%
-59.49K
2023Q3
401
61.90M
129.48%
-512.07K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
RA Capital Management, LP
10.28M
16.59%
--
--
Sep 30, 2025
Westfield Capital Management Company, L.P.
5.26M
8.49%
-191.49K
-3.51%
Sep 30, 2025
Avoro Capital Advisors LLC
5.11M
8.24%
+130.00K
+2.61%
Sep 30, 2025
Janus Henderson Investors
4.32M
6.98%
-104.73K
-2.37%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.12M
6.65%
-59.30K
-1.42%
Sep 30, 2025
Artisan Partners Limited Partnership
3.72M
6%
-269.54K
-6.75%
Sep 30, 2025
Capital International Investors
3.06M
4.94%
+13.69K
+0.45%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.67M
4.3%
-916.93K
-25.59%
Sep 30, 2025
MFS Investment Management
1.88M
3.03%
-18.93K
-1.00%
Sep 30, 2025
Wellington Management Company, LLP
1.80M
2.9%
+880.84K
+95.94%
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Harbor Health Care ETF
17.71%
American Century Focused Dynamic Growth ETF
2.8%
AdvisorShares Dorsey Wright ADR ETF
2.62%
Virtus LifeSci Biotech Products ETF
1.89%
Tema Heart & Health ETF
1.45%
ProShares Ultra Nasdaq Biotechnology
1.2%
Invesco Nasdaq Biotechnology ETF
1.19%
First Trust Innovation Leaders ETF
1.18%
Putnam Sustainable Future ETF
1.11%
Main Thematic Innovation ETF
1.07%
詳細を見る
Harbor Health Care ETF
比率17.71%
American Century Focused Dynamic Growth ETF
比率2.8%
AdvisorShares Dorsey Wright ADR ETF
比率2.62%
Virtus LifeSci Biotech Products ETF
比率1.89%
Tema Heart & Health ETF
比率1.45%
ProShares Ultra Nasdaq Biotechnology
比率1.2%
Invesco Nasdaq Biotechnology ETF
比率1.19%
First Trust Innovation Leaders ETF
比率1.18%
Putnam Sustainable Future ETF
比率1.11%
Main Thematic Innovation ETF
比率1.07%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
